ENXTPA:BIMMedical Equipment
Is New PCR Test Suite Expansion Altering The Investment Case For bioMérieux (ENXTPA:BIM)?
In recent weeks, bioMérieux has launched its GENE-UP PROBIOTIC SPECIES ID PCR solution in the U.S. and submitted new BIOFIRE gastrointestinal and SPOTFIRE vaginitis panels to the FDA, targeting faster and more comprehensive infectious disease and probiotic testing.
These moves deepen the company’s molecular diagnostics offering, extend its reach into women’s health and quality control labs, and highlight the xPRO Program’s role in co-developing next-generation assays with industry...